WSTAM
ALXN

Wilbanks Smith & Thomas Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-282
Closed -$39K – 1456
2018
Q3 		$39K Buy
+282
New +$39K ﹤0.01% 736